Daewoong :
20 Years of Growth with Indonesia
Since 2005, Daewoong has been a key partner in Indonesia’s pharmaceutical and biopharmaceutical industry. From establishing the country’s first GMP biopharmaceutical plant to launching Indonesia’s first biosimilar, Daewoong has led innovation in Indonesian healthcare. Through scholarship programs, research institutes, and social contributions, Daewoong continues to nurture local talent and expand medical access. In 2024, we obtained GMP certification for stem cell production and launched the DF Korean Center in Bali, marking a new chapter of collaboration and innovation. Daewoong remains committed to advancing healthcare and growing together with Indonesia.